Mishcon de Reya page structure
Site header
Main menu
Main content section
Page content

Inside Life Sciences

Issue 8: July 2019

Inside Life Sciences
Editor's Note Post

Editor's Note

This edition picks out some notable developments in the constant battle relating to innovator drugs and generics/biosimilars.

Blockchain – the future for Life Sciences? News

Blockchain – the future for Life Sciences?

The hype surrounding blockchain technology shows no sign of slowing down. While much of the attention has considered its impact on the financial sector, there are many other sectors where its use is being explored. One area is healthcare.

CMA continues its focus on the pharma sector News

CMA continues its focus on the pharma sector

The Competition and Markets Authority has continued its vigorous inquiry into the pharmaceutical sector in Q2, issuing two statement of objections ("SO"), and publically identifying the sector as a continuing "priority".

SPC waiver in operation from 1 July 2019 News

SPC waiver in operation from 1 July 2019

Generic and biosimilars manufacturers will soon find it easier and quicker to launch their products following publication of an EU Regulation which provides an exception to infringement of a supplementary protection certificate (SPC), known as the 'SPC waiver'.

Previous Issues

How can we help you?
Help

How can we help you?

Subscribe: I'd like to keep in touch

If your enquiry is urgent please call +44 20 3321 7000

I'm a client

I'm looking for advice

Something else